CVS Health (CVS) Shares Bought by Valley National Advisers Inc.

Valley National Advisers Inc. boosted its position in shares of CVS Health (NYSE:CVS) by 92.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 29,641 shares of the pharmacy operator’s stock after purchasing an additional 14,249 shares during the period. Valley National Advisers Inc.’s holdings in CVS Health were worth $2,149,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Wealthcare Advisory Partners LLC boosted its stake in shares of CVS Health by 330.3% in the 3rd quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 991 shares during the period. Fieldpoint Private Securities LLC boosted its stake in shares of CVS Health by 333.3% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 1,000 shares during the period. Cerebellum GP LLC purchased a new position in shares of CVS Health in the 4th quarter valued at about $130,000. Capital Analysts LLC boosted its stake in shares of CVS Health by 240.1% in the 4th quarter. Capital Analysts LLC now owns 3,177 shares of the pharmacy operator’s stock valued at $137,000 after buying an additional 2,243 shares during the period. Finally, Valeo Financial Advisors LLC purchased a new position in shares of CVS Health in the 3rd quarter valued at about $159,000. Institutional investors own 83.97% of the company’s stock.

CVS has been the subject of several recent research reports. Raymond James upgraded CVS Health from an “outperform” rating to a “strong-buy” rating and set a $90.00 price objective for the company in a research note on Thursday, January 4th. They noted that the move was a valuation call. Morgan Stanley upgraded CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 price objective for the company in a research note on Friday, January 5th. Bank of America decreased their price objective on CVS Health from $91.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, April 11th. Mizuho set a $95.00 price objective on CVS Health and gave the company a “buy” rating in a research note on Wednesday, January 24th. Finally, Needham & Company LLC lifted their price objective on CVS Health from $85.00 to $88.00 and gave the company a “buy” rating in a research note on Tuesday, January 2nd. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. CVS Health presently has an average rating of “Buy” and a consensus target price of $86.65.

In other CVS Health news, EVP Helena Foulkes sold 19,965 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the transaction, the executive vice president now owns 65,072 shares of the company’s stock, valued at $4,622,714.88. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.61% of the company’s stock.

Shares of NYSE CVS opened at $65.12 on Monday. The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59. CVS Health has a fifty-two week low of $60.14 and a fifty-two week high of $84.00. The stock has a market cap of $66,066.33, a PE ratio of 11.04, a price-to-earnings-growth ratio of 1.11 and a beta of 1.05.

CVS Health (NYSE:CVS) last issued its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.88 by $0.04. The business had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The business’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $1.71 EPS. equities analysts forecast that CVS Health will post 6.32 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 3rd. Shareholders of record on Monday, April 23rd will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 3.07%. The ex-dividend date of this dividend is Friday, April 20th. CVS Health’s dividend payout ratio (DPR) is 33.90%.

COPYRIGHT VIOLATION WARNING: “CVS Health (CVS) Shares Bought by Valley National Advisers Inc.” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3381450/cvs-health-cvs-shares-bought-by-valley-national-advisers-inc.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Critical Analysis: Intercontinental Exchange  & BGC Partners
Critical Analysis: Intercontinental Exchange & BGC Partners
Glen Harbor Capital Management LLC Purchases 91,308 Shares of Owens-Illinois Inc
Glen Harbor Capital Management LLC Purchases 91,308 Shares of Owens-Illinois Inc
Glen Harbor Capital Management LLC Sells 3,080 Shares of Mettler-Toledo International Inc.
Glen Harbor Capital Management LLC Sells 3,080 Shares of Mettler-Toledo International Inc.
Acorn Energy  & VSE  Critical Analysis
Acorn Energy & VSE Critical Analysis
Pure Storage  and Seagate Technology  Critical Contrast
Pure Storage and Seagate Technology Critical Contrast
Envestnet Asset Management Inc. Has $4.14 Million Position in Arch Capital Group
Envestnet Asset Management Inc. Has $4.14 Million Position in Arch Capital Group


© 2006-2018 Ticker Report. Google+.